Lasmiditan Succinate

證據等級: L5

預測適應症: 0 個

---

目錄

1. Lasmiditan Succinate
2. Lasmiditan Succinate: Evaluation on Hold — Insufficient Data
   1. One-Sentence Summary
   2. Quick Overview
   3. Safety Considerations
   4. Conclusion and Next Steps
   5. Disclaimer

---

## 藥師評估報告

Lasmiditan Succinate: Evaluation on Hold — Insufficient Data

One-Sentence Summary

Lasmiditan Succinate is a drug currently with no registered authorizations in Finland. This Evidence Pack contains no TxGNN predicted indications, and critical data gaps — including mechanism of action, original approved indications, and safety information — prevent any substantive repurposing evaluation at this stage. Without predicted indication data, evidence level assessment and clinical trial review cannot be conducted.

Quick Overview

Item	Content
Original Indication	Not available in this Evidence Pack
Predicted New Indication	None returned by TxGNN
TxGNN Prediction Score	Not available
Evidence Level	L5 — model prediction data absent
Finland Market Status	Not marketed
Number of Authorizations	0
Recommended Decision	Hold

Safety Considerations

Please refer to the package insert for safety information.

Conclusion and Next Steps

Decision: Hold

Rationale: This Evidence Pack contains no TxGNN predicted indications and is missing all foundational drug data required for evaluation; no repurposing candidate analysis can be performed until these gaps are resolved.

To proceed, the following is needed:

• TxGNN prediction results — the predicted_indications array is empty; re-run the TxGNN pipeline for this drug to obtain candidate indications with scores and evidence links
• Mechanism of action (MOA) — query DrugBank API (DrugBank record was found per query log ID 3, but MOA was not extracted into the Evidence Pack)
• Original approved indication(s) — original_indications is empty; retrieve from the package insert (query log ID 4 indicates a successful fetch — extract and populate)
• Safety warnings and contraindications — package insert was successfully retrieved (query log ID 4); parse and populate key_warnings and contraindications
• Drug interaction data — DDI query returned not_found; consider querying alternative sources (e.g., DrugBank interaction API, SFINX)

  Disclaimer

This content is for research purposes only and does not constitute medical advice. Clinical validation is required before any clinical application.

---